ConductScience.org, home

Trial · NCT05498714

Improved Bowel Cleansing Method for Colonoscopy Based on High Risk Population of Bowel Preparation

NCT05498714, Not applicable, Unknown, Renmin Hospital of Wuhan University

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Improved Bowel Cleansing Method for Colonoscopy Based on High Risk Population of Bowel Preparation. Trials, record NCT05498714. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05498714

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Improved Bowel Cleansing Method for Colonoscopy Based on High Risk Population of Bowel Preparation
NCT number
NCT05498714
Status
Unknown
Phases
Not applicable
Enrollment
150 participants, estimated
Lead sponsor
Renmin Hospital of Wuhan University
Conditions
Bowel Preparation Before Colonoscopy
Interventions
PEG+lactulose, CSP+lactulose
First posted
2022-08-12
Last updated
2022-08-25

Source ClinicalTrials.gov

Registered outcomes9

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryBoston Bowel Preparation Scaleduring colonoscopy
Cleanliness of the colon during colonoscopy will be evaluated by the Boston Bowel Preparation Scale which is a 4-point scoring system applied to each of 3 broad regions of the colon: the right side, the transverse section, and the left side. The total BBPS score ranged from 0 to 9. If total BostonBowel Preparation Score ≥6 with each segmental BBPS≥2, we regard it as adequate bowel preparation.
SecondaryAdenoma Detection Rate2 daysDiagnosis was confirmed by histologic examination
SecondaryPolyp Detection Rate2 daysDiagnosis was confirmed by histologic examination
SecondaryRate of adverse events2 daysadverse events, such as vomiting, nausea, headache, abdominal distention, abdominal pain.
SecondaryCecal intubation rateduring colonoscopyColonoscopy reaches cecal region.
SecondaryCecal intubation timeduring colonoscopyColonoscopy reaches cecal region.
SecondaryWithdrawal timeduring colonoscopyThe time from the cecum to the anus, but excluded time for biopsy performance or removal of polyps.
Secondarydefecation frequency2 daysFrequency of bowel movement.
Secondarypatient satisfaction Assessment2 days
Patients' satisfaction score for bowel preparation (3 points: completely tolerable and very satisfied; 2 points: nausea and other discomfort, but still tolerable and satisfactory; 1: unable to tolerate, not satisfied); And whether the patient is willing to use the bowel cleansing program for colonoscopy;

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT05498714

GET https://conductscience.org/api/trials/v1/NCT05498714/registered